• 2005

Company Description

Founded in 2005 as a result of interdisciplinary research at the Karolinska Institute in Stockholm, Sweden.

Vironova bring new solutions to the field of sub-visible particle analysis. Vironova offers a range of products and services which can be used in development of particles for vaccines, drug delivery and gene therapy as well as viral safety testing and material quality control.